Journal of Biosciences and Medicines

Vol.5 No.10(2017), Paper ID 79900, 11 pages

DOI:10.4236/jbm.2017.510007

 

Gemcitabine and Doxorubicin Combination Enhance the Cytotoxic Effect to Pancreatic Cancer Cells BxPC3 and PANC1 through UMP/CMP Kinase 1

 

Shuxian Chen, Xu Wang, Xianghui Ye, Jian Jin

 

Laboratory of Molecular Pharmacology, School of Pharmaceutical Science, Jiangnan University, Wuxi, China
Laboratory of Molecular Pharmacology, School of Pharmaceutical Science, Jiangnan University, Wuxi, China
Laboratory of Molecular Pharmacology, School of Pharmaceutical Science, Jiangnan University, Wuxi, China
Laboratory of Molecular Pharmacology, School of Pharmaceutical Science, Jiangnan University, Wuxi, China

 

Copyright © 2017 Shuxian Chen, Xu Wang, Xianghui Ye, Jian Jin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Chen, S. , Wang, X. , Ye, X. and Jin, J. (2017) Gemcitabine and Doxorubicin Combination Enhance the Cytotoxic Effect to Pancreatic Cancer Cells BxPC3 and PANC1 through UMP/CMP Kinase 1. Journal of Biosciences and Medicines, 5, 64-74. doi: 10.4236/jbm.2017.510007.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.